17:26 IST
BSE
Partnership
Ipca Laboratories Partnership
Ipca Laboratories entered a global licensing pact with BRL for subcutaneous biologics delivery technology. This partnership targets affordable monoclonal antibody development for oncology and inflammatory diseases.